[1]郭秋明,黄二苟.替普瑞酮联合改良四联疗法治疗Hp阳性胃溃疡的效果及对患者心理状态的影响[J].医学信息,2023,36(20):153-156.[doi:10.3969/j.issn.1006-1959.2023.20.031]
　GUO Qiu-ming,HUANG Er-gou.Effect of Teprenone Combined with Modified Quadruple Therapy on Hp Positive Gastric Ulcer and its Effect on Psychological State[J].Journal of Medical Information,2023,36(20):153-156.[doi:10.3969/j.issn.1006-1959.2023.20.031]
点击复制

替普瑞酮联合改良四联疗法治疗Hp阳性胃溃疡的效果及对患者心理状态的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年20期
页码:
153-156
栏目:
论著
出版日期:
2023-10-15

文章信息/Info

Title:
Effect of Teprenone Combined with Modified Quadruple Therapy on Hp Positive Gastric Ulcer and its Effect on Psychological State
文章编号:
1006-1959（2023）20-0153-04
作者:
郭秋明; 黄二苟
（1.吉水县妇幼保健院医务科，江西 吉水 331600；2.吉水县人民医院精神科，江西 吉水 331600）
Author(s):
GUO Qiu-ming; HUANG Er-gou
(1.Medical Department of Jishui County Maternal and Child Health Hospital,Jishui 331600,Jiangxi,China;2.Psychiatric Department of Jishui County People’s Hospital,Jishui 331600,Jiangxi,China)
关键词:
幽门螺杆菌; 胃溃疡; 改良四联疗法; 替普瑞酮
Keywords:
Helicobacter pylori; Gastric ulcer; Modified quadruple therapy; Teprenone
分类号:
R573.3
DOI:
10.3969/j.issn.1006-1959.2023.20.031
文献标志码:
A
摘要:
目的 研究替普瑞酮联合改良四联疗法治疗幽门螺杆菌（Hp）阳性胃溃疡的临床效果及对患者心理状态的影响。方法 以2019年12月-2020年12月吉水县妇幼保健院收治的60例Hp阳性胃溃疡患者为研究对象，按照随机数字表法分为对照组（30例）与观察组（30例），对照组给予改良四联疗法治疗（泮托拉唑+阿莫西林+克拉霉素+枸橼酸铋钾），观察组则在其基础上加用替普瑞酮治疗，比较两组胃溃疡疗效、Hp根除率、溃疡直径、胃黏膜损伤Lanza评分、心理状态[焦虑自评量表（SAS）、抑郁自评量表（SDS）]、生活质量[消化性溃疡患者生命质量测定量表（QLICD-PU）]。结果 观察组胃溃疡治疗有效率高于对照组（P＜0.05），但两组Hp根除率比较，差异无统计学意义（P＞0.05）；两组治疗后溃疡直径、胃黏膜损伤Lanza评分均小于治疗前，且观察组溃疡直径、胃黏膜损伤Lanza评分小于对照组（P＜0.05）；两组治疗后SAS、SDS评分低于治疗前，且观察组SAS、SDS评分低于对照组（P＜0.05）；两组治疗后QLICD-PU评分（生理功能、心理功能、社会功能、特异模块）均高于治疗前，且观察组QLICD-PU评分（生理功能、心理功能、社会功能、特异模块）高于对照组（P＜0.05）。结论 替普瑞酮联合改良四联疗法治疗Hp阳性胃溃疡效果良好，可促进溃疡愈合，减少胃粘膜损伤，改善患者的心理状态及生活质量。
Abstract:
Objective To study the clinical effect of teprenone combined with modified quadruple therapy in the treatment of Helicobacter pylori (Hp) positive gastric ulcer and its influence on the psychological state of patients.Methods Sixty patients with Hp-positive gastric ulcer admitted to Jishui County Maternal and Child Health Hospital from December 2019 to December 2020 were enrolled in the study. They were divided into control group (30 patients) and observation group (30 patients) according to the random number table method. The control group was treated with modified quadruple therapy (pantoprazole+amoxicillin+clarithromycin+bismuth potassium citrate), and the observation group was treated with teprenone on the basis of it. The efficacy of gastric ulcer, Hp eradication rate, ulcer diameter, Lanza score of gastric mucosal injury, psychological status [Self-rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS)] and quality of life [Quality of Life Instruments for Chronic Diseases-Peptic Ulcer (QLICD-PU)] were compared between the two groups.Results The effective rate of gastric ulcer treatment in the observation group was higher than that in the control group (P<0.05), but there was no significant difference in the eradication rate of Hp between the two groups (P>0.05). The ulcer diameter and Lanza score of gastric mucosal injury in the two groups after treatment were lower than those before treatment, and the ulcer diameter and Lanza score of gastric mucosal injury in the observation group were lower than those in the control group (P<0.05). The SAS and SDS scores of the two groups after treatment were lower than those before treatment, and the SAS and SDS scores of the observation group were lower than those of the control group (P<0.05). The QLICD-PU scores (physiological function, psychological function, social function, specific module) of the two groups after treatment were higher than those before treatment, and the QLICD-PU scores (physiological function, psychological function, social function, specific module) of the observation group were higher than those of the control group (P<0.05).Conclusion Teprenone combined with modified quadruple therapy is effective in the treatment of Hp positive gastric ulcer, which can promote ulcer healing, reduce gastric mucosal injury, and improve the psychological state and quality of life of patients.

参考文献/References:

[1]董浩,金世禄,朱凤鸣,等.磷酸铝凝胶联合兰索拉唑对Hp阳性胃溃疡患者HP清除率及血清MMP-9、GAS水平变化的影响[J].中国地方病防治杂志,2017,32(9):1057,1059.[2]Khatoon J,Prasad KN,Prakash R,et al.Association of heterogenicity of Helicobacter pylori cag pathogenicity island with peptic ulcer diseases and gastric cancer[J].British Journal of Biomedical Science,2017,74(3):121-126.[3]The Canadian Association of Gastroenterology.The Toronto Consensus for the Treatment of Helicobacter pylori Infection in adults[J].Gastroenterology,2016,18:S00165085.[4]罗酩,吴永梅,李文娟,等.四联疗法对幽门螺杆菌相关性胃溃疡的疗效及对胃黏膜形态学的影响[J].山西医药杂志,2021,50(10):1698-1699.[5]刘慧,郁磊,张诒凤,等.替普瑞酮改良四联疗法治疗幽门螺旋杆菌阳性胃溃疡患者效果及对胃黏膜形态、TGF-β、Smad 3、胃肠激素影响[J].临床误诊误治,2020,33(5):38-43.[6]娄书伟,仝亚旭.替普瑞酮对萎缩性胃炎伴幽门螺杆菌感染患者的疗效及对胃黏膜的影响[J].广东医学,2019,40(3):450-454.[7]Bagheri N,Shirzad H,Elahi S,et al.Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection[J].Microbial Pathogenesis,2017,110:165-175.[8]贺继东,张军鹏,董丽娟,等.替普瑞酮联合奥美拉唑胶囊治疗重度糜烂性胃炎并发消化不良疗效及对患者肠胃功能的影响研究[J].陕西医学杂志,2019,48(10):1390-1392.[9]于子涵,陈凌,肖静,等.四联药物方案治疗胃溃疡的临床疗效和安全性研究[J].实用药物与临床,2019,22(2):159-161.[10]王聪.四联疗法对不同CYP2C19型幽门螺杆菌相关性胃溃疡患者基质金属蛋白酶和金属蛋白酶组织抑制剂1表达的影响[J].中国药物与临床,2022,22(3):208-211.[11]刘宏伟,黄玉洁,杨剑英,等.铝碳酸镁、兰索拉唑、阿莫西林、呋喃唑酮四联疗法治疗幽门螺杆菌相关性胃溃疡的效果及安全性评价[J].中国综合临床,2020,36(1):22-27.[12]贺亚妮,安毅,穆亚娟,等.叶酸和替普瑞酮联合三联疗法对老年Hp阳性慢性萎缩性胃炎患者血清G-17、PG及免疫功能的影响[J].解放军医药杂志,2018,30(9):89-92.[13]白芳芸,郑红英,冯雅宁,等.酪酸梭菌联合四联疗法治疗幽门螺杆菌阳性胃溃疡的作用机制研究[J].中国现代医学杂志,2017,27(9):83-86.[14]徐露,朱瑞华,朱佳玲.四联疗法对幽门螺杆菌相关性胃溃疡的疗效及对胃黏膜形态学的影响[J].临床消化病杂志,2017,29(3):136-139.[15]刁凌云,王胜英,皇金萍.替普瑞酮联合复胃散治疗慢性萎缩性胃炎的疗效观察[J].中国现代医学杂志,2018,28(25):76-79.[16]吴晋.替普瑞酮治疗老年HP阳性慢性萎缩性胃炎临床效果分析[J].陕西医学杂志,2021,50(6):735-737,762.[17]钱欢欢,崔立红.替普瑞酮治疗幽门螺杆菌阴性萎缩性胃炎的临床疗效[J].中国新药杂志,2017,26(7):791-794.[18]杜志娜,尉迟敏,曲韬.泮托拉唑四联疗法加用胃黏膜保护剂对幽门螺杆菌阳性胃溃疡患者愈合质量的影响[J].实用医院临床杂志,2017,14(3):112-114.[19]Zhao J,Fan Y,Ye W,et al.The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries[J].Gastroenterology Research and Practice,2019,1(5):1-7.[20]Gong Y,Huang X,Chen M,et al.Teprenone improves gastric mucosal injury and dyspeptic symptoms in long‐term nonsteroidal anti‐inflammatory drug users[J].Journal of Gastroenterology and Hepatology,2019,34(8):1344-1350.

相似文献/References:

[1]郭绍敏.克拉霉素四联方案对一线方案根除失败的幽门螺杆菌的再根除效果评估[J].医学信息,2018,31(02):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
　GUO Shao-min.Evaluation of the Re-eradication Effect of Clarithromycin Quadruple Regimen on Helicobacter Pylori Eradication Failure in the First Line Scheme[J].Journal of Medical Information,2018,31(20):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
[2]罗宜辉,刘代华.益生菌联合四联方案根除幽门螺杆菌的临床研究[J].医学信息,2018,31(11):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
　LUO Yi-hui,LIU Dai-hua.Clinical Study on the Eradication of Helicobacter Pylori by Probiotics Combined with Quadruple Regimen[J].Journal of Medical Information,2018,31(20):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
[3]潮子健,汪文生,谢宏伟.年龄对胃部常见良性疾病患者的胃蛋白酶原及胃泌素-17水平的影响[J].医学信息,2018,31(23):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
　CHAO Zi-jian,WANG Wen-sheng,XIE Hong-wei.Effect of Age on Pepsinogen and Gastrin-17 Levels in Patients with Common Benign Diseases of the Stomach[J].Journal of Medical Information,2018,31(20):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
[4]朱爱娥,王菊艳.系统护理干预对慢性胃炎及胃溃疡患者临床疗效及生活质量的影响研究[J].医学信息,2019,32(04):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
　ZHU Ai-e,WANG Ju-yan.Effect of Systematic Nursing Intervention on Clinical Efficacy and Quality of Life in Patients with Chronic Gastritis and Stomach Ulcer[J].Journal of Medical Information,2019,32(20):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
[5]华启洋,吴同利,刘永艳,等.幽门螺杆菌在胃食管反流病发病中的作用[J].医学信息,2019,32(20):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
　HUA Qi-yang,WU Tong-li,LIU Yong-yan,et al.The Role of Helicobacter Pylori in the Pathogenesis of Gastroesophageal Reflux Disease[J].Journal of Medical Information,2019,32(20):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
[6]王晓琼,曾凡玲.体检者胃溃疡检出率及其影响因素分析[J].医学信息,2019,32(23):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
　WANG Xiao-qiong,ZENG Fan-ling.Analysis of the Detection Rate of Gastric Ulcer and its Influencing Factors in Physical Examination Patients[J].Journal of Medical Information,2019,32(20):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
[7]陶源,徐俊林,张艳,等.上消化道黏膜病变病理诊断结果分析[J].医学信息,2020,33(02):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
　TAO Yuan,XU Jun-lin,ZHANG Yan,et al.Analysis of Pathological Diagnosis for Upper Gastrointestinal Mucosal Lesions[J].Journal of Medical Information,2020,33(20):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
[8]张运林.铝碳酸镁片联合雷贝拉唑Hp感染合并活动性消化性溃疡的安全性[J].医学信息,2020,33(24):125.[doi:10.3969/j.issn.1006-1959.2020.24.035]
　ZHANG Yun-lin.The Safety of Hydrotalcite Tablets Combined with Rabeprazole Hp Infection with Active Peptic Ulcer[J].Journal of Medical Information,2020,33(20):125.[doi:10.3969/j.issn.1006-1959.2020.24.035]
[9]刘敏芝,李运泽.幽门螺杆菌的治疗现状[J].医学信息,2021,34(15):35.[doi:10.3969/j.issn.1006-1959.2021.15.010]
　LIU Min-zhi,LI Yun-ze.Current Status of Treatment of Helicobacter Pylori[J].Journal of Medical Information,2021,34(20):35.[doi:10.3969/j.issn.1006-1959.2021.15.010]
[10]周 政.胃息肉与幽门螺杆菌感染的关系[J].医学信息,2021,34(21):91.[doi:10.3969/j.issn.1006-1959.2021.21.023]
　ZHOU Zheng.Relationship Between Gastric Polyps and Helicobacter Pylori Infection[J].Journal of Medical Information,2021,34(20):91.[doi:10.3969/j.issn.1006-1959.2021.21.023]
[11]黄 飞.不同用药方案治疗幽门螺杆菌感染胃溃疡的效果比较[J].医学信息,2020,33(16):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
　HUANG Fei.Comparison of the Effects of Different Medication Regimens in the Treatment of Gastric Ulcer Infected by Helicobacter Pylori[J].Journal of Medical Information,2020,33(20):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
[12]王蓓蓓,白 梅.黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响[J].医学信息,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
　WANG Bei-bei,BAI Mei.Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer[J].Journal of Medical Information,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
[13]张 静,张鸿博.中医药治疗幽门螺杆菌相关性胃溃疡研究[J].医学信息,2022,35(20):173.[doi:10.3969/j.issn.1006-1959.2022.20.048]
　ZHANG Jing,ZHANG Hong-bo.Study on Traditional Chinese Medicine Treatment of Helicobacter Pylori Associated Gastric Ulcer[J].Journal of Medical Information,2022,35(20):173.[doi:10.3969/j.issn.1006-1959.2022.20.048]

更新日期/Last Update: 1900-01-01